Press Releases

 
Press Releases
Date Title and Summary View
Mar 11, 2015 NOVATO, Calif., March 11, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that on March 9, 2015, the Compensation Committee of the Company's Board of Directors approved grants of inducement stock options to purchase an aggregate of 152,867 shares of common stock to six new employees and a grant of 10,714 Restricte...
Feb 26, 2015 Global Net Product Sales for PROCYSBI® of $69.5 Million for 2014 2015 PROCYSBI Revenue Guidance of $80-$90 MillionCompany to Host Conference Call and Webcast Today at 4:30 p.m. ET/1:30 p.m. PT NOVATO, Calif., Feb. 26, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) reported financial results for the fourth quarter and ye...
Feb 23, 2015 NOVATO, Calif., Feb. 23, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced its support of Rare Disease Day on February 28, 2015 with a series of initiatives and events meant to celebrate advancements in the field of rare and orphan diseases and to support and strengthen patient communities. The company joins EURORDI...
Feb 18, 2015 NOVATO, Calif., Feb. 18, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that Michael Smith, Chief Financial Officer will participate in the following investor conferences: SunTrust Robinson Humphrey Biotechnology and Pharmaceutical One-on-One Orphan Drug Day on Monday, February 23, 2015, at the JW E...
Feb 17, 2015 NOVATO, Calif., Feb. 17, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that the company will release fourth quarter and full year 2014 financial results on Thursday, February 26, 2015 after market close. Management will conduct a conference call and live audio webcast at 4:30 p.m. ET (1:30 p.m. PT) that day to d...
Feb 10, 2015 NOVATO, Calif., Feb. 10, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that the Lysosomal Disease Network (LDN) will present Raptor Pharmaceutical with the 2015 New Treatment Award for PROCYSBI® (cysteamine bitartrate) delayed-release capsules on February 12, 2015 at its 11th Annual WORLD Symposium being he...
Jan 30, 2015 NOVATO, Calif., Jan. 30, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it will present at the following conference: Julie Anne Smith, President and Chief Executive Officer, will participate in a fireside chat at the 2015 Leerink Global Healthcare Conference on Thursday, February 12, 2015, at 1...
Jan 20, 2015 NOVATO, Calif., Jan. 20, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that on January 15, 2015, a majority of the independent members of the Company's Board of Directors approved inducement stock option awards to new hire employees pursuant to the Raptor Pharmaceutical Corp. 2014 Employment Commencement Stock I...
Jan 7, 2015 NOVATO, Calif., Jan. 7, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced the appointment of Krishna R. Polu, M.D., as its Chief Medical Officer and Michael P. Smith as Chief Financial Officer, effective January 12, 2015. Dr. Polu will oversee all global clinical development programs, medical affairs and other relat...
Dec 18, 2014 NOVATO, Calif., Dec. 18, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced the appointment of Gregg Lapointe and Georges Gemayel, Ph.D. to its Board of Directors, effective January 1, 2015. As previously disclosed, they will be joining Julie Anne Smith, President and CEO-Designate as she succeeds Christopher Starr, ...
Page:
1
... NextLast
= add release to Briefcase